Long‐Term Safety and Tolerability of Apremilast Versus Placebo in Psoriatic Arthritis: A Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials

OBJECTIVE: Psoriatic arthritis (PsA) requires long‐term treatment, yet safety concerns and monitoring requirements make maintenance a challenge. This analysis of pooled Psoriatic Arthritis Long‐term Assessment of Clinical Efficacy (PALACE) 1, 2, and 3 data describes 3‐year apremilast safety and tole...

Descripción completa

Detalles Bibliográficos
Autores principales: Mease, Philip J., Gladman, Dafna D., Gomez‐Reino, Juan J., Hall, Stephen, Kavanaugh, Arthur, Lespessailles, Eric, Schett, Georg, Paris, Maria, Delev, Nikolay, Teng, Lichen, Wollenhaupt, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437129/
https://www.ncbi.nlm.nih.gov/pubmed/32710493
http://dx.doi.org/10.1002/acr2.11156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437129/
https://www.ncbi.nlm.nih.gov/pubmed/32710493
http://dx.doi.org/10.1002/acr2.11156

Ejemplares similares